Management of multicellular senescence and oxidative stress

Journal of Cellular and Molecular Medicine

Volumn 17, Issue 8, 2013, Pages 936-957

  Haines, David D ^a   Juhasz, Bela ^a   Tosaki, Arpad ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Apoptosis; Autophagy; Necroptosis; Necrosis; Oxidative stress; Senescence

Indexed keywords

ACTINIARIA; ANEMONE; ANTHOZOA; CNIDARIA; MAMMALIA; MUS; SCYPHOZOA;

REACTIVE OXYGEN METABOLITE;

ANIMAL; APOPTOSIS; ARTICLE; AUTOPHAGY; CELL AGING; HUMAN; METABOLISM; NECROPTOSIS; NECROSIS; OXIDATIVE STRESS; PHENOTYPE; SENESCENCE;

APOPTOSIS; AUTOPHAGY; NECROPTOSIS; NECROSIS; OXIDATIVE STRESS; SENESCENCE;

ANIMALS; CELL AGING; HUMANS; OXIDATIVE STRESS; PHENOTYPE; REACTIVE OXYGEN SPECIES;

EID: 84888198183     PISSN: 15821838     EISSN: None     Source Type: Journal    
DOI: 10.1111/jcmm.12074     Document Type: Article

References (111)

1. Bredesen DE. The non-existent aging program: how does it work? Aging Cell. 2004; 3: 255-9.
2. Garry DJ, Masino AM, Naseem RH, et al. Ponce de Leon's Fountain: stem cells and the regenerating heart. Am J Med Sci. 2005; 329: 190-201.
3. Campisi J. Senescent cells, tumor suppression, and organismal aging: good citizens, bad neighbors. Cell. 2005; 120: 513-22.
4. Hayflick L. The limited in vitro lifetime of human diploid cell strains. Exp Cell Res. 1965; 37: 614-36.
5. Stanley JF, Pye D, MacGregor A. Comparison of doubling numbers attained by cultured animal cells with life span of species. Nature. 1975; 255: 158-9.
6. Soldstein S. Aging in vitro. Growth of cultured cells from the Galapagos tortoise. Exp Cell Res. 1974; 83: 297-302.
7. Salk D, Bryant E, Au K, et al. Systematic growth studies, cocultivation, and cell hybridization studies of Werner syndrome cultured skin fibroblasts. Hum Genet. 1981; 58: 310-6.
8. Santrock JW. A topical approach to life-span development. New York: McGraw-Hill; 2002.
9. Kaplan H, Hill K, Lancaster J, et al. A theory of human life history evolution: diet, intelligence, and longevity. Evol Anthropol. 2000; 9: 156-85.
10. Olovnikov AM. Telomeres, telomerase, and aging: origin of the theory. Exp Gerontol. 1996; 31: 443-8.
11. McFarland GA, Holliday R. Retardation of the senescence of cultured human diploid fibroblasts by carnosine. Exp Cell Res. 1994; 212: 167-75.
12. Shao L, Li QH, Tan Z. L-carnosine reduces telomere damage and shortening rate in cultured normal fibroblasts. Biochem Biophys Res Commun. 2004; 324: 931-6.
13. Feng J, Funk WD, Wang SS, et al. The RNA component of human telomerase. Science. 1995; 269: 1236-41.
14. Jaskelioff M, Muller FL, Paik JH, et al. Telomerase reactivation reverses tissue degeneration in aged telomerase-deficient mice. Nature. 2011; 469: 102-6.
15. Wright WE, Shay JW. Telomere dynamics in cancer progression and prevention: fundamental differences in human and mouse telomere biology. Nat Med. 2000; 6: 849-51.
16. Macville M, Schrock E, Padilla-Nash H, et al. Comprehensive and definitive molecular cytogenetic characterization of HeLa cells by spectral karyotyping. Cancer Res. 1999; 59: 141-50.
17. Masters JR. HeLa cells 50 years on: the good, the bad and the ugly. Nat Rev Cancer. 2002; 2: 315-9.
18. Hayflick L. How and why we age. Exp Gerontol. 1998; 33: 639-53.
19. Cristofalo VJ, Allen RG, Pignolo RJ, et al. Relationship between donor age and the replicative lifespan of human cells in culture: a reevaluation. Proc Natl Acad Sci USA. 1998; 95: 10614-9.
20. Melk A, Kittikowit W, Sandhu I, et al. Cell senescence in rat kidneys in vivo increases with growth and age despite lack of telomere shortening. Kidney Int. 2003; 63: 2134-43.
21. Hara H, Araya J, Takasaka N, et al. Involvement of creatine kinase B in cigarette smoke induced-bronchial epithelial cell senescence. Am J Respir Cell Mol Biol. 2012; 46(3): 306-12.
22. Campisi J. Cellular senescence and apoptosis: how cellular responses might influence aging phenotypes. Exp Gerontol. 2003; 38: 5-11.
23. Baker DJ, Wijshake T, Tchkonia T, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479: 232-6.
24. Noctor SC, Martinez-Cerdeno V, Kriegstein AR. Contribution of intermediate progenitor cells to cortical histogenesis. Arch Neurol. 2007; 64: 639-42.
25. Herrup K, Yang Y. Cell cycle regulation in the postmitotic neuron: oxymoron or new biology? Nat Rev Neurosci. 2007; 8: 368-78.
26. Hanahan D, Weinberg RA. Hallmarks of cancer: the next generation. Cell. 2011; 144: 646-74.
27. Blagosklonny MV. Progeria, rapamycin and normal aging: recent breakthrough. Aging. 2011; 3: 685-91.
28. Hay N, Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004; 18: 1926-45.
29. Hyttinen JM, Petrovski G, Salminen A, et al. 5'-adenosine monophosphate-activated protein kinase-mammalian target of rapamycin axis as therapeutic target for age-related macular degeneration. Rejuvenation Res. 2011; 14(6): 651-60.
30. Lahti JM, Xiang J, Heath LS, et al. PITSLRE protein kinase activity is associated with apoptosis. Mol Cell Biol. 1995; 15: 1-11.
31. Smith CC, Yellon DM. Necroptosis, necrostatins and tissue injury. J Cell Mol Med. 2011; 15: 1797-806.
32. Wyllie AH, Kerr JF, Currie AR. Cell death: the significance of apoptosis. Int Rev Cytol. 1980; 68: 251-306.
33. Berghe TV, Vanlangenakker N, Parthoens E, et al. Necroptosis, necrosis and secondary necrosis converge on similar cellular disintegration features. Cell Death Differ. 2010; 17: 922-30.
34. Thompson RF, Einstein FH. Epigenetic basis for fetal origins of age-related disease. J Womens Health. 2010; 19: 581-7.
35. Mochizuki K, Matsui Y. Epigenetic profiles in primordial germ cells: global modulation and fine tuning of the epigenome for acquisition of totipotency. Dev Growth Differ. 2010; 52: 517-25.
36. Yang HC, Rossini M, Ma LJ, et al. Cells derived from young bone marrow alleviate renal aging. J Am Soc Nephrol. 2011; 22: 2028-36.
37. Goswitz VC, Sawicki ZP. Cancer therapy based on a mechanism of action for controlling the immune system and the resulting patent portfolio. Recent Pat Endocr Metab Immune Drug Discov. 2013; 7(1): 1-10.
38. Steiner D. Computer algorithms in the search for unrelated stem cell donors. Bone Marrow Res. 2012; 2012: 175419.
39. Prather WR, Toren A, Meiron M. Placental-derived and expanded mesenchymal stromal cells (PLX-I) to enhance the engraftment of hematopoietic stem cells derived from umbilical cord blood. Expert Opin Biol Ther. 2008; 8: 1241-50.
40. Owen M, Friedenstein AJ. Stromal stem cells: marrow-derived osteogenic precursors. Ciba Found Symp. 1988; 136: 42-60.
41. Rasmusson I. Immune modulation by mesenchymal stem cells. Exp Cell Res. 2006; 312: 2169-79.
42. Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy. 2006; 8: 315-7.
43. Le Blanc K, Ringden O. Mesenchymal stem cells: properties and role in clinical bone marrow transplantation. Curr Opin Immunol. 2006; 18: 586-91.
44. Chen T, Shen L, Yu J, et al. Rapamycin and other longevity-promoting compounds enhance the generation of mouse induced pluripotent stem cells. Aging Cell. 2011; 10: 908-11.
45. Conboy IM, Conboy MJ, Wagers AJ, et al. Rejuvenation of aged progenitor cells by exposure to a young systemic environment. Nature. 2005; 433: 760-4.
46. Sansone P, Storci G, Tavolari S, et al. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J Clin Invest. 2007; 117: 3988-4002.
47. Toussaint O, Dumont P, Remacle J, et al. Stress-induced premature senescence or stress-induced senescence-like phenotype: one in vivo reality, two possible definitions? ScientificWorldJournal. 2002; 2: 230-47.
48. Pospelova TV, Demidenko ZN, Bukreeva EI, et al. Pseudo-DNA damage response in senescent cells. Cell Cycle. 2009; 8: 4112-8.
49. Nakamura M, Morisawa H, Imajoh-Ohmi S, et al. Proteomic analysis of protein complexes in human SH-SY5Y neuroblastoma cells by using blue-native gel electrophoresis: an increase in lamin A/C associated with heat shock protein 90 in response to 6-hydroxydopamine-induced oxidative stress. Exp Gerontol. 2009; 44: 375-82.
50. McClintock D, Gordon LB, Djabali K. Hutchinson-Gilford progeria mutant lamin A primarily targets human vascular cells as detected by an anti-Lamin A G608G antibody. Proc Natl Acad Sci USA. 2006; 103: 2154-9.
51. Liu B, Zhou Z. Lamin A/C, laminopathies and premature ageing. Histol Histopathol. 2008; 23: 747-63.
52. Scaffidi P, Misteli T. Lamin A-dependent misregulation of adult stem cells associated with accelerated ageing. Nat Cell Biol. 2008; 10: 452-9.
53. Ferdinandy P, Schulz R, Baxter GF. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev. 2007; 59: 418-58.
54. Ovize M, Baxter GF, Di Lisa F, et al. Postconditioning and protection from reperfusion injury: where do we stand? Position paper from the Working Group of Cellular Biology of the Heart of the European Society of Cardiology. Cardiovasc Res. 2010; 87: 406-23.
55. Cao K, Graziotto JJ, Blair CD, et al. Rapamycin reverses cellular phenotypes and enhances mutant protein clearance in Hutchinson-Gilford progeria syndrome cells. Sci Transl Med. 2011; 3: 89ra58.
56. Fang Y, Vilella-Bach M, Bachmann R, et al. Phosphatidic acid-mediated mitogenic activation of mTOR signaling. Science. 2001; 294: 1942-5.
57. Kim DH, Sarbassov DD, Ali SM, et al. mTOR interacts with raptor to form a nutrient-sensitive complex that signals to the cell growth machinery. Cell. 2002; 110: 163-75.
58. Altomare I, Hurwitz H. Everolimus in colorectal cancer. Expert Opin Pharmacother. 2013; 14: 505-13.
59. Haines DD, Bak I, Ferdinandy P, et al. Cardioprotective effects of the calcineurin inhibitor FK506 and the PAF receptor antagonist and free radical scavenger, EGb 761, in isolated ischemic/reperfused rat hearts. J Cardiovasc Pharmacol. 2000; 35: 37-44.
60. Das A, Salloum FN, Durrant D, et al. Rapamycin protects against myocardial ischemia-reperfusion injury through JAK2-STAT3 signaling pathway. J Mol Cell Cardiol. 2012; 53: 858-69.
61. Devasagayam TP, Tilak JC, Boloor KK, et al. Free radicals and antioxidants in human health: current status and future prospects. J Assoc Physicians India. 2004; 52: 794-804.
62. Hockenbery DM, Oltvai ZN, Yin XM, et al. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell. 1993; 75: 241-51.
63. Martin SJ, Green DR. Protease activation during apoptosis: death by a thousand cuts? Cell. 1995; 82: 349-52.
64. Lazebnik YA, Kaufmann SH, Desnoyers S, et al. Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE. Nature. 1994; 371: 346-7.
65. Schulz JB, Weller M, Klockgether T. Potassium deprivation-induced apoptosis of cerebellar granule neurons: a sequential requirement for new mRNA and protein synthesis, ICE-like protease activity, and reactive oxygen species. J Neurosci. 1996; 16: 4696-706.
66. Martin SJ, O'Brien GA, Nishioka WK, et al. Proteolysis of fodrin (non-erythroid spectrin) during apoptosis. J Biol Chem. 1995; 270: 6425-8.
67. Miura M, Zhu H, Rotello R, et al. Induction of apoptosis in fibroblasts by IL-1 beta-converting enzyme, a mammalian homolog of the Caenorhabditis elegans cell death gene ced-3. Cell. 1993; 75: 653-60.
68. Amstad P, Crawford D, Muehlematter D, et al. Oxidants stress induces the proto-oncogenes, C-fos and C-myc in mouse epidermal cells. Bull Cancer. 1990; 77: 501-2.
69. Wolf CM, Reynolds JE, Morana SJ, et al. The temporal relationship between protein phosphatase, ICE/CED-3 proteases, intracellular acidification, and DNA fragmentation in apoptosis. Exp Cell Res. 1997; 230: 22-7.
70. Zimmerman R, Cerutti P. Active oxygen acts as a promoter of transformation in mouse embryo C3H/10T1/2/C18 fibroblasts. Proc Natl Acad Sci USA. 1984; 81: 2085-7.
71. Winterbourn CC, Metodiewa D. The reaction of superoxide with reduced glutathione. Arch Biochem Biophys. 1994; 314: 284-90.
72. Borrello S, De Leo ME, Galeotti T. Defective gene expression of MnSOD in cancer cells. Mol Aspects Med. 1993; 14: 253-8.
73. Minhas HS, Thornalley PJ. Reduced glutathione esters-antidotes to toxicity. Cytotoxicity induced by hydrogen peroxide, 1-chloro-2, 4-dinitrobenzene, and menadione in murine P388D1 macrophages in vitro. J Biochem Toxicol. 1995; 10: 245-50.
74. Shoji Y, Uedono Y, Ishikura H, et al. DNA damage induced by tumour necrosis factor-alpha in L929 cells is mediated by mitochondrial oxygen radical formation. Immunology. 1995; 84: 543-8.
75. Lazebnik YA, Takahashi A, Moir RD, et al. Studies of the lamin proteinase reveal multiple parallel biochemical pathways during apoptotic execution. Proc Natl Acad Sci USA. 1995; 92: 9042-6.
76. Kumar S. ICE-like proteases in apoptosis. Trends Biochem Sci. 1995; 20: 198-202.
77. Lee RK, Spielman J, Zhao DY, et al. Perforin, Fas ligand, and tumor necrosis factor are the major cytotoxic molecules used by lymphokine-activated killer cells. J Immunol. 1996; 157: 1919-25.
78. Tomasovic SP, Lu S, Klostergaard J. Comparative in vitro studies of the potentiation of tumor necrosis factor (TNF)-alpha, TNF-beta, and TNF-SAM2 cytotoxicity by hyperthermia. J Immunother. 1991; 1992: 85-92.
79. Clement MV, Stamenkovic I. Superoxide anion is a natural inhibitor of FAS-mediated cell death. EMBO J. 1996; 15: 216-25.
80. Boldin MP, Goncharov TM, Goltsev YV, et al. Involvement of MACH, a novel MORT1/FADD-interacting protease, in Fas/APO-1- and TNF receptor-induced cell death. Cell. 1996; 85: 803-15.
81. Henkart PA. ICE family proteases: mediators of all apoptotic cell death? Immunity. 1996; 4: 195-201.
82. Schulze-Osthoff K, Krammer PH, Droge W. Divergent signalling via APO-1/Fas and the TNF receptor, two homologous molecules involved in physiological cell death. EMBO J. 1994; 13: 4587-96.
83. Voelkel-Johnson C, Entingh AJ, Wold WS, et al. Activation of intracellular proteases is an early event in TNF-induced apoptosis. J Immunol. 1995; 154: 1707-16.
84. Pernollet M, Villiers C, Gabert F, et al. OH. treatment of tetanus toxin reduces its susceptibility to limited proteolysis with more efficient presentation to specific T cells. Mol Immunol. 1993; 30: 1639-46.
85. Petrovski G, Das DK. Does autophagy take a front seat in lifespan extension? J Cell Mol Med. 2010; 14: 2543-51.
86. Burtner CR, Kennedy BK. Progeria syndromes and ageing: what is the connection? Nat Rev Mol Cell Biol. 2010; 11: 567-78.
87. Benson EK, Lee SW, Aaronson SA. Role of progerin-induced telomere dysfunction in HGPS premature cellular senescence. J Cell Sci. 2010; 123: 2605-12.
88. Harrison DE, Strong R, Sharp ZD, et al. Rapamycin fed late in life extends lifespan in genetically heterogeneous mice. Nature. 2009; 460: 392-5.
89. Demidenko ZN, Zubova SG, Bukreeva EI, et al. Rapamycin decelerates cellular senescence. Cell Cycle. 2009; 8: 1888-95.
90. Hands SL, Proud CG, Wyttenbach A. mTOR's role in ageing: protein synthesis or autophagy? Aging. 2009; 1: 586-97.
91. Berger Z, Ravikumar B, Menzies FM, et al. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum Mol Genet. 2006; 15: 433-42.
92. Renna M, Jimenez-Sanchez M, Sarkar S, et al. Chemical inducers of autophagy that enhance the clearance of mutant proteins in neurodegenerative diseases. J Biol Chem. 2010; 285: 11061-7.
93. Powers RW 3rd, Kaeberlein M, Caldwell SD, et al. Extension of chronological life span in yeast by decreased TOR pathway signaling. Genes Dev. 2006; 20: 174-84.
94. Pan KZ, Palter JE, Rogers AN, et al. Inhibition of mRNA translation extends lifespan in Caenorhabditis elegans. Aging Cell. 2007; 6: 111-9.
95. Kapahi P, Zid BM, Harper T, et al. Regulation of lifespan in Drosophila by modulation of genes in the TOR signaling pathway. Curr Biol. 2004; 14: 885-90.
96. Mueller MA, Beutner F, Teupser D, et al. Prevention of atherosclerosis by the mTOR inhibitor everolimus in LDLR-/- mice despite severe hypercholesterolemia. Atherosclerosis. 2008; 198: 39-48.
97. Zhao L, Ding T, Cyrus T, et al. Low-dose oral sirolimus reduces atherogenesis, vascular inflammation and modulates plaque composition in mice lacking the LDL receptor. Br J Pharmacol. 2009; 156: 774-85.
98. Rodriguez AE, Granada JF, Rodriguez-Alemparte M, et al. Oral rapamycin after coronary bare-metal stent implantation to prevent restenosis: the Prospective, Randomized Oral Rapamycin in Argentina (ORAR II) Study. J Am Coll Cardiol. 2006; 47: 1522-9.
99. Mandache E, Gherghiceanu M, Macarie C, et al. Telocytes in human isolated atrial amyloidosis: ultrastructural remodelling. J Cell Mol Med. 2010; 14: 2739-47.
100. Cretoiu D, Cretoiu SM, Simionescu AA, et al. Telocytes, a distinct type of cell among the stromal cells present in the lamina propria of jejunum. Histol Histopathol. 2012; 27: 1067-78.
101. Cretoiu SM, Cretoiu D, Popescu LM. Human myometrium - the ultrastructural 3D network of telocytes. J Cell Mol Med. 2012; 16: 2844-9.
102. Zhao B, Chen S, Liu J, et al. Cardiac telocytes were decreased during myocardial infarction and their therapeutic effects for ischaemic heart in rat. J Cell Mol Med. 2013; 17: 123-33.
103. Polykandriotis E, Popescu LM, Horch RE. Regenerative medicine: then and now-an update of recent history into future possibilities. J Cell Mol Med. 2010; 14: 2350-8.
104. Cretoiu SM, Cretoiu D, Marin A, et al. Telocytes: ultrastructural, immunohistochemical and electrophysiological characteristics in human myometrium. Reproduction. 2013; 145: 357-70.
105. Hoke NN, Salloum FN, Kass DA, et al. Preconditioning by phosphodiesterase-5 inhibition improves therapeutic efficacy of adipose-derived stem cells following myocardial infarction in mice. Stem Cells. 2012; 30: 326-35.
106. Speakman JR, Mitchell SE. Caloric restriction. Mol Aspects Med. 2011; 32: 159-221.
107. Bak I, Czompa A, Csepanyi E, et al. Evaluation of systemic and dermal toxicity and dermal photoprotection by sour cherry kernels. Phytother Res. 2011; 25: 1714-20.
108. Kubota S. Evolutionary meaning of non-synchronous medusa release and spawning in the most advanced bivalve-inhabiting hydrozoan, Eugymnanthea japonica. Zoolog Sci. 2012; 29: 481-3.
109. Schmich J, Kraus Y, De Vito D, et al. Induction of reverse development in two marine Hydrozoans. Int J Dev Biol. 2007; 51: 45-56.
110. Piraino S, Boero F, Aeschbach B, et al. Reversing the life cycle: medusae transforming into polyps and cell transdifferentiation in Turritopsis nutricula (Cnidaria, Hydrozoa). Biol Bull. 1996; 190: 302-12.
111. Biedlingmaier JF, Trifillis A. Comparison of CT scan and electron microscopic findings on endoscopically harvested middle turbinates. Otolaryngol Head Neck Surg. 1998; 118: 165-73.